These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 8252542

  • 1. Accumulation of pentamannose oligosaccharides in human mononuclear leukocytes by action of swainsonine, an inhibitor of glycoprotein processing.
    Kang MS, Bowlin TL, Vijay IK, Sunkara SP.
    Carbohydr Res; 1993 Oct 04; 248():327-37. PubMed ID: 8252542
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing.
    Bowlin TL, McKown BJ, Kang MS, Sunkara PS.
    Cancer Res; 1989 Aug 01; 49(15):4109-13. PubMed ID: 2501020
    [Abstract] [Full Text] [Related]

  • 3. 1-Deoxymannojirimycin inhibits capillary tube formation in vitro. Analysis of N-linked oligosaccharides in bovine capillary endothelial cells.
    Nguyen M, Folkman J, Bischoff J.
    J Biol Chem; 1992 Dec 25; 267(36):26157-65. PubMed ID: 1464626
    [Abstract] [Full Text] [Related]

  • 4. Developmental regulation of asparagine-linked oligosaccharide synthesis in Dictyostelium discoideum.
    Sharkey DJ, Kornfeld R.
    J Biol Chem; 1991 Oct 05; 266(28):18485-97. PubMed ID: 1917971
    [Abstract] [Full Text] [Related]

  • 5. Swainsonine causes the production of hybrid glycoproteins by human skin fibroblasts and rat liver Golgi preparations.
    Tulsiani DR, Touster O.
    J Biol Chem; 1983 Jun 25; 258(12):7578-85. PubMed ID: 6408079
    [Abstract] [Full Text] [Related]

  • 6. Effects of the alpha-mannosidase inhibitors, 1,4-dideoxy-1,4-imino-D-mannitol and swainsonine, on glycoprotein catabolism in cultured macrophages.
    Daniel PF, Newburg DS, O'Neil NE, Smith PW, Fleet GW.
    Glycoconj J; 1989 Jun 25; 6(2):229-40. PubMed ID: 2535594
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of N-linked oligosaccharide processing does not prevent the secretion of thyroglobulin. A study with swainsonine and deoxynojirimycin.
    Franc JL, Hovsepian S, Fayet G, Bouchilloux S.
    Eur J Biochem; 1986 May 15; 157(1):225-32. PubMed ID: 2940087
    [Abstract] [Full Text] [Related]

  • 8. 1,4-Dideoxy-1,4-imino-D-mannitol inhibits glycoprotein processing and mannosidase.
    Palamarczyk G, Mitchell M, Smith PW, Fleet GW, Elbein AD.
    Arch Biochem Biophys; 1985 Nov 15; 243(1):35-45. PubMed ID: 4062306
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a mannosidase acting on alpha 1----3- and alpha 1----6-linked mannose residues of oligomannosidic intermediates of glycoprotein processing.
    Monis E, Bonay P, Hughes RC.
    Eur J Biochem; 1987 Oct 15; 168(2):287-94. PubMed ID: 3665925
    [Abstract] [Full Text] [Related]

  • 10. A human lysosomal alpha(1----6)-mannosidase active on the branched trimannosyl core of complex glycans.
    Daniel PF, Evans JE, De Gasperi R, Winchester B, Warren CD.
    Glycobiology; 1992 Aug 15; 2(4):327-36. PubMed ID: 1421754
    [Abstract] [Full Text] [Related]

  • 11. Swainsonine is a useful tool to monitor the intracellular traffic of N-linked glycoproteins as a function of the state of enterocytic differentiation of HT-29 cells.
    Houri JJ, Ogier-Denis E, Bauvy C, Aubery M, Sapin C, Trugnan G, Codogno P.
    Eur J Biochem; 1992 May 01; 205(3):1169-74. PubMed ID: 1577000
    [Abstract] [Full Text] [Related]

  • 12. Ricin-resistant mutants of baby-hamster-kidney cells deficient in alpha-mannosidase-II-catalyzed processing of asparagine-linked oligosaccharides.
    Hughes RC, Feeney J.
    Eur J Biochem; 1986 Jul 15; 158(2):227-37. PubMed ID: 3732270
    [Abstract] [Full Text] [Related]

  • 13. Swainsonine: an inhibitor of glycoprotein processing.
    Elbein AD, Solf R, Dorling PR, Vosbeck K.
    Proc Natl Acad Sci U S A; 1981 Dec 15; 78(12):7393-7. PubMed ID: 6801650
    [Abstract] [Full Text] [Related]

  • 14. Posttranslational protein modification: biosynthetic control mechanisms in the glycosylation of the major myelin glycoprotein by Schwann cells.
    Poduslo JF.
    J Neurochem; 1985 Apr 15; 44(4):1194-206. PubMed ID: 2579205
    [Abstract] [Full Text] [Related]

  • 15. Properties of baby-hamster kidney (BHK) cells treated with Swainsonine, an inhibitor of glycoprotein processing. Comparison with ricin-resistant BHK-cell mutants.
    Foddy L, Feeney J, Hughes RC.
    Biochem J; 1986 Feb 01; 233(3):697-706. PubMed ID: 3085652
    [Abstract] [Full Text] [Related]

  • 16. Role of target cell glycoproteins in sensitivity to natural killer cell lysis.
    Ahrens PB.
    J Biol Chem; 1993 Jan 05; 268(1):385-91. PubMed ID: 8093244
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression.
    Korczak B, Dennis JW.
    Int J Cancer; 1993 Feb 20; 53(4):634-9. PubMed ID: 8436437
    [Abstract] [Full Text] [Related]

  • 18. The storage products in genetic and swainsonine-induced human mannosidosis.
    Cenci di Bello I, Dorling P, Winchester B.
    Biochem J; 1983 Dec 01; 215(3):693-6. PubMed ID: 6419731
    [Abstract] [Full Text] [Related]

  • 19. Abnormal glycosylation of human cellular fibronectin in the presence of swainsonine.
    Arumugham RG, Tanzer ML.
    J Biol Chem; 1983 Oct 10; 258(19):11883-9. PubMed ID: 6413506
    [Abstract] [Full Text] [Related]

  • 20. Swainsonine prevents the processing of the oligosaccharide chains of influenza virus hemagglutinin.
    Elbein AD, Dorling PR, Vosbeck K, Horisberger M.
    J Biol Chem; 1982 Feb 25; 257(4):1573-6. PubMed ID: 6799507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.